ARCHIVES

MSKCC oncologist settles insider trading case with SEC.

This article is from The Cancer Letter archive.

Vol. 31 No. 41 | November 11, 2005

Download PDF Visit The Full Archive

Related Articles

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

First Lady Helps Dedicate New MDA Facilities

October 15, 1976

Capitol Hill: Mammography Quality standards Act Reintroduced

April 18, 1997

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991

In Brief: Wells, Gardner, Brennan Lead Surgical Oncology; Young, Flynn, Are New officers For Head & Neck

March 26, 1993